Arca
Skip to content
Tools
Tools

CCKBR: Gastrin/cholecystokinin type B receptor

Receptor for the peptide hormones gastrin and cholecystokinin (CCK).

  • Drugs that act on it: 3
  • Approved: 0
  • In phases 1 to 3: 3
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on CCKBR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2
  • Protein or peptide 1

Approved0

    Phase 30

      Phase 22

      • Itriglumide
      • Netazepide

      Phase 11

      • CI-988

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Cholecystokinin B receptor antagonist.
      ItriglumidePhase 2—Small moleculeAntagonist0
      NetazepidePhase 2Trio Medicines Ltd.Protein or peptideAntagonist0
      CI-988Phase 1—Small moleculeAntagonist0

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      • Peptic ulcer disease0.46
      • Gastroesophageal reflux disease0.44
      • Hypercholesterolemia, familial, 10.33
      • Esophageal disorder0.28
      • Mathematical ability0.15
      • Duodenal disorder0.13
      • Stomach disorder0.13
      • Neoplasm0.11
      • Pancreatic neoplasm0.10
      • Chronic atrophic gastritis0.10

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL298, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P32239, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.